In stroke pathology, NMDAR1-abs seropositivity was previously linked to beneficial effects due to the presumed effects of NMDAR1-abs on NMDA receptor-mediated excitotoxicity [8, 9, 25]. This evidence concerns the gene GRIN1 and Stroke.